Clinical trial · Interventional
Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients
NCT03951090CI-TRIAL-00038644completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study prospectively evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in a cohort of non-electively hospitalized older (\> 70 years) adults with cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oncology | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No results of brief geriatric assessments | Other | — | UNRESOLVED |
| Results of the brief geriatric assessment | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- GARRT Arm
- description
- Participants in this arm complete an brief geriatric assessment, and the results of these assessments are given to providers with recommendations to address deficits identified by the geriatric assessment
- interventionNames
- Other: Results of the brief geriatric assessment
- type
- ACTIVE_COMPARATOR
- label
- Control Arm
- description
- Providers of participants of this group will not receive the results of the brief geriatric assessments. These participants will receive standard of care treatment
- interventionNames
- Other: No results of brief geriatric assessments
Primary outcomes (1)
- measure
- Referral rate for GA-identified deficits in intervention and control groups
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Age 70 years or older. * English speaking. * Admitted to UNC Hospitals non-electively within 72 hours. * Biopsy proven solid tumor or myeloma or lymphoma. * Newly diagnosed cancer patients for whom active cancer directed therapy is planned within the next six months or patients on active cancer directed therapy either currently or within the previous 6 months. * Signed written IRB-approved informed consent. Exclusion Criteria: * Patients meeting any of the following exclusion criteria at baseline will be excluded from study participation. Patients with a life expectancy \<6 weeks * Patients who are \<48 hours post-surgery. * Patients who are admitted to an intensive care setting. * Patients with acute myeloma lymphoma (AML) or other high grade hematologic malignancies. * Patients undergoing bone marrow transplant or admitted to the bone marrow transplant unit.
References
Publications (0)
Data not yet available
No reference posted for this study.